Search

Search Constraints

You searched for: Author/Creator Andersen, Jesper B.

Search Results

1. Abstracts Presented by Attendees. (February 2016)

2. Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification. Issue 11 (14th December 2018)

3. Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy. Issue 4 (20th May 2019)

4. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids. Issue 6 (8th February 2022)

6. DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration. Issue 2 (28th April 2016)

8. Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells. Issue 4 (5th July 2021)

9. Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. Issue 3 (12th June 2018)

10. High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. Issue 9 (17th May 2017)